Welsh decision-makers approve funding of cannabidiol (Epidyolex®) for TSC-related refractory epilepsy, allowing access to the medicine in Wales

The Welsh Government has today (Friday 10 December) approved a recommendation from the All-Wales Medicines Strategy Group (AWMSG) that cannabidiol (brand name Epidyolex®) is funded within Wales for TSC-related refractory epilepsy, meaning that people living with TSC in Wales will be able to access